Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Degradable Solutions is a Swiss medical device company specializing in the development and manufacture of resorbable implants and synthetic bone graft substitutes. Founded in 1999 as a spin-off from ETH Zurich, the company provides contract development and manufacturing (CDMO) services for high-quality biodegradable materials used in dental and orthopedic applications. Their product portfolio includes the GUIDOR and easy-graft lines, which facilitate bone regeneration without the need for a second surgery to remove the implant. Since 2011, the company has operated as part of the Sunstar Group, leveraging its expertise in polymer chemistry and processing to serve global healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Degradable Solutions.